TrademarkDir
ZIXXIVUS
DEAD

Serial Number

88581818

Owner

Vanda Pharmaceuticals Inc.

Attorney

Jayme M. Torelli

Filing Date

Aug 16, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ZIXXIVUS Trademark

Serial Number: 88581818

ZIXXIVUS is a trademark filed by Vanda Pharmaceuticals Inc. on August 16, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Vanda Pharmaceuticals Inc. (104 trademarks)

Suite 300
Rockville, MD 20850

Entity Type: 03

Trademark Details

Filing Date

August 16, 2019

Registration Date

Not Registered

Published for Opposition

June 23, 2020

Goods & Services

Pharmaceutical preparations for use in the treatment of diseases and disorders, namely, circadian rhythm diseases and disorders, Non-24-Hour Sleep-Wake Disorder, jet lag disorder, Smith-Magenis Syndrome, Delayed Sleep Phase Disorder, bipolar disorder, schizophrenia, atopic dermatitis, pruritus, craving, gastroparesis, motion sickness, and hematologic malignancies

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 18, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 18, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 7, 2023 EXRA
SOU EXTENSION 5 GRANTED
Mar 6, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 3, 2023 AITU
SOU EXTENSION 5 FILED
Feb 17, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Feb 17, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 16, 2022 EXRA
SOU EXTENSION 4 GRANTED
Jul 14, 2022 EX4G
SOU EXTENSION 4 FILED
Jul 14, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 14, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 29, 2021 EXRA
SOU EXTENSION 3 GRANTED
Dec 27, 2021 EX3G
SOU EXTENSION 3 FILED
Dec 27, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 27, 2021 EEXT
ASSIGNED TO EXAMINER
Aug 23, 2021 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 6, 2021 EXRA
SOU EXTENSION 2 GRANTED
Jul 2, 2021 EX2G
SOU EXTENSION 2 FILED
Jul 2, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 2, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 21, 2021 EXRA
SOU EXTENSION 1 GRANTED
Jan 18, 2021 EX1G
SOU EXTENSION 1 FILED
Jan 18, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 18, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 18, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 23, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 23, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 3, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 19, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 6, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 5, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 5, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 20, 2019 GNRN
NON-FINAL ACTION E-MAILED
Nov 20, 2019 GNRT
NON-FINAL ACTION WRITTEN
Nov 20, 2019 CNRT
ASSIGNED TO EXAMINER
Nov 17, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 3, 2019 NWOS
NEW APPLICATION ENTERED
Aug 20, 2019 NWAP

Related Trademarks

More from this Owner

NEREUS 85MG (TRADIPITANT) CAPSULES logo

NEREUS 85MG (TRADIPITANT) CAPSULES

NEREUS (TRADIPITANT) logo

NEREUS (TRADIPITANT)

NEREUS (TRADIPITANT) CAPSULES logo

NEREUS (TRADIPITANT) CAPSULES

Trademark logo

Serial #99839209

DELOSRX

DELOSRX

QUIMILZA

QUIMILZA